Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lantheus Germany Gmbh

Clinical trials sponsored by Lantheus Germany Gmbh, explained in plain language.

Now part of Lantheus Holdings, Inc. LNTH NASDAQ

German subsidiary of Lantheus, a company specializing in diagnostic imaging agents.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

New PET tracer could spot rare heart disease without a biopsy

Diagnosis Completed

This completed Phase 3 study tested whether a radioactive tracer called [18F]Florbetaben, used in PET scans, can accurately diagnose cardiac AL amyloidosis—a condition where abnormal proteins build up in the heart. 244 adults with suspected cardiac amyloidosis received a single P…

Phase: PHASE3 • Sponsor: Lantheus Germany GmbH • Aim: Diagnosis

Last updated Aug 05, 2026 00:00 UTC